检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Progression Free Survival (Pfs), And Event Free Survival (Efs) From A Global Randomized Phase 3 Study Of Guadecitabine (G) Vs Treatment Choice (Tc) In 815 Patients With Treatment Naive (Tn) Aml Unfit For Intensive Chemotherapy (Ic): Astral-1 Study

Jean-Pierre Issa,Marco Gobbi,Patricia L. Kropf,Pierre Fenaux,Gail J. Roboz,Jiri Mayer,Jürgen Krauter,Tadeusz Robak,Hagop M. Kantarjian,Jan Novak,Wieslaw W. Jedrzejczak,Xavier Thomas,Mario Ojeda-Uribe,Yasushi Miyazaki,Yoo Hong Min,Su-Peng Yeh,Joseph M Brandwein,Liana Gercheva,Judit Demeter,Elizabeth A. Griffiths,Karen W.L. Yee,Yong Hao,Mohammad Azab,Hartmut Döhner

BLOOD（2019）

引用 0|浏览83
暂无评分
摘要
BACKGROUND© 2019 Astex Pharmaceuticals, Inc. Pleasanton, CA Poster presented at: ASH Annual meeting, Orlando, FL Dec. 7–10, 2019
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要